Gujarat Kidney IPO GMP (Grey Market Premium)
As of now, the Gujarat Kidney IPO GMP is awaited. GMP usually gives a short-term sentiment check, but remember—fundamentals matter more than grey market noise.
Financial Performance Analysis
Let’s look at how the company has performed financially.
Revenue Growth Trend (₹ in Crores)
-
- FY2023: 85.79
-
- FY2024: 103.44
-
- FY2025: 119.97
Revenue growth shows a consistent upward trajectory, indicating expanding operations and increasing patient footfall.
Profitability and Margin Expansion
-
- Net Profit FY2023: 6.35
-
- Net Profit FY2025: 15.13
-
- Net Margin improved from 7.40% to 12.61%
This is a strong indicator of operational efficiency and cost control.
